Oct 9, 2008 By San Diego Suburban News - La Jolla Light
Dr. Ernest Beutler, a Scripps Research Institute physician and researcher who was one of the country's leading experts on diseases of the blood and iron metabolism, has died of lymphoma. He was 80.
Beutler died Sunday at Scripps Green Hospital in La Jolla, the Los Angeles Times reported.
Beutler was a pioneer in bone marrow transplantation for fighting cancer; made key discoveries about the role of the X-chromosome in women; helped discover G6PD deficiency, the most common clinically significant enzyme deficiency of humans; improved the diagnosis and treatment of Gaucher disease; and developed cladribine, a treatment for both leukemia and multiple sclerosis, according to The Times.
He also wrote the original programming for the widely used software Reference Manager.
"Ernie always had a sparkle in his eye, the energy of a man half his age and a bottomless treasury of new ideas,'' Dr. Richard A. Lerner, president of Scripps, told The Times. He "was a truly extraordinary man who led an exceptional life, full of kindness, wisdom, strength and knowledge.''
Beutler was born in Berlin to two physicians and moved to America in 1935.
He is survived by his wife of 58 years, four children and eight grandchildren.
Although the La Jolla Light does not have any obligation to monitor this board, the La Jolla Light reserves the right at all times to check this board and to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable to the La Jolla Light in our sole discretion and to disclose any information necessary to satisfy the law, regulation, or government request. The La Jolla Light also reserves the right to permanently block any user who violates these terms and conditions. All threats to systems or site infrastructure shall be assumed genuine in nature and will be reported to the appropriate law enforcement authorities. Submission of any comments will be considered permission to use online or in print.
